Recce Pharmaceuticals completes global patent portfolio
–News Direct– Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham joins Proactives Jonathan Jackson to talk through the formal granting of a new Patent Family 2 by the China National Intellectual Property Administration. The patent, titled 'Copolymer and Method for Treatment of Bacterial Infection', covers RECCE 327 (R327) and RECCE 529 (R529). These compounds are used…